TransCode Therapeutics (RNAZ) Revenue & Revenue Breakdown
TransCode Therapeutics Revenue Highlights
TransCode Therapeutics Revenue by Period
TransCode Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
TransCode Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
TransCode Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $753.15K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | - |
TransCode Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
TransCode Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| XBIO | Xenetic Biosciences | $2.54M | $510.82K |
| SONN | Sonnet BioTherapeutics | $147.81K | - |
| EYEN | Eyenovia | $3.79K | $4.99K |
| CNSP | CNS Pharmaceuticals | - | - |
| ZURA | Zura Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| CGTX | Cognition Therapeutics | - | - |
| PHIO | Phio Pharmaceuticals | - | - |
| ZVSA | ZyVersa Therapeutics | - | - |
| KOD | Kodiak Sciences | - | - |
| IMMX | Immix Biopharma | - | - |
| ONCR | Oncorus | - | - |
| RNAZ | TransCode Therapeutics | - | - |
| LABP | Landos Biopharma | - | - |
| EFTR | eFFECTOR Therapeutics | - | - |
| NEXI | NexImmune | - | - |
RNAZ Revenue FAQ
What is TransCode Therapeutics’s yearly revenue?
TransCode Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. RNAZ's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is TransCode Therapeutics’s quarterly revenue?
TransCode Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). RNAZ's quarterly revenue for Q4 2023 was $753.15K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is TransCode Therapeutics’s revenue growth rate?
TransCode Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.